跳转至内容
Merck
CN

1.00490

SAFC

Parteck®口腔崩解片

EMPROVE® ESSENTIAL

制药生产

登录查看公司和协议定价


About This Item

UNSPSC代码:
12352107

产品线

EMPROVE® ESSENTIAL

质量水平

表单

fine powder

粒径

80-220 μm (d50)

应用

pharmaceutical
solid formulation

储存温度

2-30°C

一般描述

With formulation challenges in mind, we have used particle engineering technologies to develop functional excipients specifically for solid dosage forms. The products in our Parteck® portfolio feature unique particle properties tailored for excellent performance in tableting processes, for specific drug delivery technologies, or for solubility enhancement.
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

应用

Parteck® ODT excipient provides rapid disintegration and exceptional strength for orally disintegrating tablets. It is well suited for direct compression processes and provides a pleasant taste and mouthfeel.

特点和优势

  • Robust tablets at low compression forces
  • Rapid disintegration and dissolution
  • No license payments
  • High dilution potential – up to 50% load of your API
  • Tablets with PARTECK® ODT excipient system are suitable for conventional coating

法律信息

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
PARTECK is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

储存分类代码

11 - Combustible Solids

WGK

WGK 1


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

商品

Our overview of API solubility and dissolution enhancement methods can help you decide between the many options to take during formulation.

This article describes the use of excipients to help address API stability issues.

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

相关内容

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门